Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Venous thrombosis: antithrombin III deficiency

M Halfman, D E Berg

    Critical Care Nursing Clinics of North America
    |September 1, 1993
    PubMed
    Summary

    Antithrombin (ATIII) deficiency significantly increases the risk of venous thrombosis due to its role as a natural anticoagulant. This review covers the pathophysiology, clinical signs, diagnosis, and treatment of this condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    H. pylori DNA Fingerprinting Using the Arbitrarily Primed PCR (AP-PCR) or Random Amplified Polymorphic DNA (RAPD) Method.

    Methods in molecular medicine·2011
    Same author

    The Nonhuman Primate Model for H. pylori Infection.

    Methods in molecular medicine·2011
    Same author

    Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives.

    Alimentary pharmacology & therapeutics·2006
    Same author

    Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy.

    Alimentary pharmacology & therapeutics·2005
    Same author

    Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents.

    Gut·2003
    Same author

    Molecular & evolutionary genetics & drug resistance of the gastric pathogen, Helicobacter pylori.

    The Indian journal of medical research·2002

    Area of Science:

    • Biochemistry
    • Hematology
    • Pathophysiology

    Background:

    • Antithrombin (ATIII) is a critical natural anticoagulant protein.
    • ATIII deficiency predisposes individuals to a high risk of venous thrombosis.

    Observation:

    • Individuals with ATIII deficiency demonstrate a marked propensity for developing venous thromboembolic events.
    • The pathophysiology involves impaired regulation of coagulation factors.

    Findings:

    • Understanding the pathophysiology of ATIII deficiency is key to managing thrombotic risk.
    • Clinical presentation can vary, necessitating accurate diagnostic approaches.

    Implications:

    • Effective diagnosis and treatment strategies are crucial for patients with ATIII deficiency.
    • Management aims to prevent recurrent thrombotic events and improve patient outcomes.

    Related Experiment Videos